Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Budenofalk - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Budenofalk

Approved

STANDARD

Budenofalk

Losan Pharma GmbH🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: d3a1e9f7beadb75d
Company: Losan Pharma GmbH
Type: Standard

Approval Details

Approval Id: d3a1e9f7beadb75d
Drug Approval Philippines Name: Budenofalk
Product Name: Budenofalk
Registration Number: DR-XY27181
Brand Name: Budenofalk
Generic Name: Budesonide
Dosage Form: Enteric-Coated Pellets in Capsule
Dosage Strength: 3 mg
Manufacturer: Losan Pharma GmbH
Trader: Dr. Falk Pharma GmbH
Importer: A. Menarini Philippines, Inc.
Distributor: A. Menarini Philippines, Inc.
Company Detail Path: /organization/losan-pharma-gmbh
Trader Detail Path: /organization/doktor-falk-farma-gmbkh-predstavitelstvo
Issuance Date: 25 May 2025
Expiry Date: 07 November 2031
Pharmacologic Category: Intestinal Anti-Inflammatory Agent
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

d3a1e9f7beadb75d

Type

Standard

Back to Philippines FDA Approvals